Alnylam Pharmaceuticals
ALNY
#634
Rank
HK$253.08 B
Marketcap
HK$1,955
Share price
0.54%
Change (1 day)
66.99%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company